NCT06395103 Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01) Status RECRUITING Phase PHASE1/PHASE2
NCT06296732 Abdominal Neuroblastoma Laparoscopic Surgery Risk Factors Stratification Status RECRUITING Phase N/A
NCT06233903 18F-mFBG Expression in Neural Crest Tumors and Organs Innervated by the Sympathetic Nervous System Status WITHDRAWN Phase PHASE2
NCT06190574 Diagnostic Efficacy and Prognostic Value of 18F-FDG PET/CT (MR) in Pediatric Solid Blastoma Status COMPLETED Phase N/A
NCT06182410 Defibrotide Prophylaxis of Transplant Associated-Thrombotic Microangiopathy for Neuroblastoma Status WITHDRAWN Phase PHASE2
NCT06172296 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma Status RECRUITING Phase PHASE3
NCT06104488 A Study of Avutometinib for People With Solid Tumor Cancers Status RECRUITING Phase PHASE1
NCT06071897 Induction Chemoimmunotherapy for Patients With High-risk Neuroblastoma Status RECRUITING Phase PHASE3
NCT06057948 A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma Status RECRUITING Phase PHASE2
NCT06047535 Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) Combined With Isotretinoin for Maintenance Treatment of Patients With High-Risk Neuroblastoma in First Complete Response. Status NOT_YET_RECRUITING Phase PHASE4
NCT06013618 Clinical Analysis of Naxitamab (hu3F8) in the Treatment of Pediatric High Risk or Refractory/ Relapsed Neuroblastoma Status RECRUITING Phase PHASE2
NCT05990751 Multi-modular Chimeric Antigen Receptor Targeting GD2 in Neuroblastoma Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05918432 Determining Patterns In Study Experiences of Neuroblastoma Patients Status NOT_YET_RECRUITING Phase N/A
NCT05826158 18F-mFBG LAFOV PET/CT Compared to 123I-mIBG Scintigraphy SPECT/CT for Evaluation of Children With Neuroblastoma Status RECRUITING Phase NA